Researchers have found that administering remdesivir with corticosteroids to Asian patients who are critically ill with COVID-19 within 9 days of symptom onset reduces overall mortality. Starting treatment later did not have the same effect, suggesting that higher viral loads and serious lung damage impair the effectiveness of this treatment.